New synthetic phage platform could reshape antimicrobial therapy
A new system lets researchers build and reprogram phage genomes from digital sequence data, potentially enabling scalable, customizable therapies for drug-resistant bacteria.
Drug Discovery News highlights an exciting advance from New England Bio Labs and Yale University: a synthetic phage engineering platform that enables phages to be designed and built entirely in the lab. Proud that Ansa could deliver the DNA for this study.
www.drugdiscoverynews.com/new-syntheti...
28.01.2026 23:50 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0
ICYMI: Weโre partnering with @ansabio.bsky.social to provide customers with access to long, #complexDNA, ranging from 100 bp to 50 kb! Take a look at how this collaboration has delivered value to Manos Papadakis, Senior Research Scientist, @dsmfirmenich.bsky.social. ๐
Read more: idtb.io/c2tiva
21.01.2026 15:03 โ ๐ 2 ๐ 1 ๐ฌ 0 ๐ 0
New partnership announcement! ๐ค
Weโre proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g
#SyntheticBiology #DNASynthesis #synbio #lifesciencesnews
14.01.2026 13:29 โ ๐ 2 ๐ 1 ๐ฌ 1 ๐ 0
๐ Big news: Ansa is partnering with @idtdna.bsky.social to expand access to enzymatic DNA synthesis worldwide. IDT customers can now get sequence-perfect DNA constructs up to 50 kb with the speed and precision researchers trust.
๐ hubs.ly/Q03-KKPM0
14.01.2026 13:52 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0
Attending #JPM26? Donโt miss hearing from Ansa CEO Jason T. Gammack at this JPM Healthcare Satellite Event!
๐
Wed, Jan 14 | 5โ8 PM
๐ 100 Montgomery St, Ste. 1200, San Francisco
Register: bit.ly/44wDkOZ
Join us for Happy Hour + Panel Discussions on AI & Biopharma Innovation.
#BIOsky #synbio
08.01.2026 15:08 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
Don't wait on slow, unreliable DNA synthesis.
โ
Order whole pathways & multi-gene systems as single constructs
โ
Tackle projects that were once โunsynthesizableโ
โ
Design from biology-first principles w/ the confidence that complex constructs will arrive on time & exactly as specified
ansabio.com
07.01.2026 16:24 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
๐ ๐ฃ๐ฅ๐๐ฆ๐ฆ ๐ฆ๐ฃ๐ข๐ง๐๐๐๐๐ง
We are excited to see @GenomeWeb spotlight Ansa and our mission to reshape what is possible in DNA synthesis.
๐ Read the article: hubs.li/Q03YDk7_0
23.12.2025 19:13 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
What would you build with 50 kb of accurate DNA delivered in under a month?
See how @appliedstemcell.bsky.social achieved a precise 50 kb knock-in using TARGATTโข + Ansa DNA synthesis.
๐ bit.ly/49jsX3G ๐งช
18.12.2025 15:37 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
In cell and gene therapy, one missing piece can derail your whole project. At Ansa, we deliver complex sequences like ITRs, regulatory regions & long inserts, so you can focus on function, not fabrication.
๐ lnkd.in/gfEe2h4U
๐งช #BIOsky
15.12.2025 11:00 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
Ending The Waiting Game: How Ansa Biotechnologies Guarantees are Turning DNA Synthesis Into A Predictable Industry
Join SynBioBeta, the global community of biological engineers, entrepreneurs, investors, and innovators working to make biology easier to engineer.
Customers deserve the same confidence ordering DNA as any other reagent, says Ansa CEO Jason T Gammack.
In this #SynBioBeta feature, he shares how Ansa delivers >97% fulfillment on long, complex constructs & why the future is shifting from buying genes to buying genomes.
๐งช bit.ly/4iX4qVE
11.12.2025 12:29 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 1
๐ก๐๐ช ๐๐๐๐๐ง๐๐ข๐ก ๐ง๐ข ๐ง๐๐ ๐ง๐๐๐ : Weโre thrilled to announce the appointment of Geoff Hamilton as Ansaโs new Chief Financial Officer and Chief Business Officer.
๐ Release: hubs.li/Q03Xvjkk0
๐ Get to know Geoff: hubs.li/Q03Xvj3H0
10.12.2025 16:17 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
Sick of scaling back experiments? We were, too. Thatโs why we founded a company to reimagine DNA synthesis from the ground up and to fundamentally change the status quo.
๐งช Experience a new kind of DNA provider: hubs.li/Q03grdRG0
#BIOsky #synbio
07.12.2025 15:20 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
Ordering synthetic DNA? Donโt do it blind.
Get our free guide, which breaks down what to watch for before placing your next orderโtimelines, QC, complexity, and true costโso you can make smarter choices with confidence.
๐ hubs.li/Q03WGW7k0
#synbio #BIOsky #syntheticDNA
04.12.2025 16:14 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0
NOW ON-DEMAND: Webinar for #genetherapy Innovators. featuring a collaboration w/ #EndoFold Bio that generated a full-length ~23 kb human dystrophin plasmid (including UTRs) in ~20 business days .
๐ Watch here: hubs.li/Q03Vg1SR0
#BIOsky #synbio ๐งช
25.11.2025 15:07 โ ๐ 2 ๐ 1 ๐ฌ 0 ๐ 0
DNA Synthesis Just Hit Its Inflection Point โฆ and Most of the Industry Isnโt Ready
For decades, the DNA synthesis world has operated under a quiet rule: this terrible service is just the way it is. Deal with it.
Scientists no longer need to shrink their imagination to match the limitations of their synthesis suppliers' capabilities. Ansa CEO Jason T Gammack explains how we are flipping the "build vs. buy" equation & making programmable biology programmable.
www.linkedin.com/pulse/dna-sy...
#BIOsky #synbio
20.11.2025 10:41 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
๐ฑ A greener way to make DNA: Ansa uses fully aqueous, enzyme-based synthesisโno harsh chemicals, less waste, and longer, cleaner constructs.
๐Learn more: ansabio.com/technology/?...
#synbio #BIOsky #sustainability #DNAsynthesis
18.11.2025 14:42 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
Genome synthesis, assembly, and rebooting of therapeutically useful high G+C% mycobacteriophages | PNAS
Bacteriophages show therapeutic promise for treating bacterial pathogens including
nontuberculous mycobacteria (NTM). A major impediment is the pau...
๐งช From ๐ฐ๐น๐ผ๐ป๐ถ๐ป๐ด to ๐ฝ๐ฟ๐ถ๐ป๐๐ถ๐ป๐ด, the field just hit turbo mode. Introducing a PNAS paper in which scientists from Pitt Bio & New England Biolabs worked with Ansa to build fully synthetic mycobacteriophage genomes (viruses) from scratch.
www.pnas.org/doi/10.1073/...
#synbio #BIOsky
13.11.2025 14:14 โ ๐ 3 ๐ 1 ๐ฌ 0 ๐ 0
Ansa Biotechnologies
<h2>Our Mission:</h2>
<h2><em>Revolutionize the way we make DNA</em></h2>
<p class="">Compared to reading or editing lifeโs code, writing new code from scratch has remained one of biotechnologyโs most...
We are scaling like crazy and have several Manufacturing Associate positions open right now to keep up with the demand.
Please share with anyone who would be interested in joining our team during this exciting time!
job-boards.greenhouse.io/ansabiotechn...
#hiring #manufacturing #sciencejobs
10.11.2025 12:57 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
๐ก๐ผ๐๐ต๐ถ๐ป๐ด ๐๐ฝ๐ฒ๐ฎ๐ธ๐ ๐น๐ผ๐๐ฑ๐ฒ๐ฟ ๐๐ต๐ฎ๐ป ๐ฐ๐๐๐๐ผ๐บ๐ฒ๐ฟ ๐๐๐ฐ๐ฐ๐ฒ๐๐.
We're grateful for this ringing endorsement from Dr. Simon Shu-Yu Wu of @ASCAppliedStem.
๐ Learn more about XL Clonal DNA: ansabio.com/products/50kb/
06.11.2025 15:18 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
๐งช We are proud to announce the launch of our 50kb Clonal DNA, the longest sequence=perfect synthetic DNA commercially available, in <25 days, backed by the industry's only On-Time Guarantee.
๐ ansabio.com/topic/news-e...
#BIOsky #SyntheticDNA
23.10.2025 15:58 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0
๐งฌ Finding the right vector just got easier โ and faster.
Announcing Ansaโs new Catalog Vectors! Skip the upfront postage & paperwork. Simply upload your sequence file, select your vector, and Ansa will ship your completed DNA to you.
๐ ansabio.com/products/vec...
07.10.2025 11:55 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0
๐ Weโve raised $54.4M in an oversubscribed Series B!
This funding powers U.S.-based manufacturing, new products, and the first DNA synthesis on-time guarantee.
๐งช Read the press release: hubs.li/Q03LHN3c0
01.10.2025 15:23 โ ๐ 4 ๐ 1 ๐ฌ 0 ๐ 0
#DYK: Ansa provides two flexible formats to help accelerate your research potential: sequence-perfect clonal DNA or sequence-verified linear double-stranded DNA fragment formats, both with up-front pricing & guaranteed delivery times.
๐งช ansabio.com/products?utm...
#BIOsky
24.09.2025 16:01 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
Don't shy away from challenging elements like hairpins, repeats, or high/low GC content. Our advanced technology is designed to handle the complexity of naturally occurring DNA, allowing you to study the biology you want, without compromise.
๐งช www.ansabio.com?utm_source=B...
23.09.2025 13:48 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
At Touchlight, reliable, on-time enzymatic DNA delivery isn't just a bonus, it's mission critical. If vendors fail, research stalls, manufacturing slots are lost, and reputations are on the line.
๐ง Hear from Alex Cotton about why his team trusts Ansa with their DNA synthesis needs.
#BIOsky ๐งช
17.09.2025 11:56 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
Attn Automation Engineers: We're #hiring!
We're seeking an associate to support the development, testing, and deployment of our laboratory automation systems, including liquid handlers, colony pickers, and other robotic instrumentation.
๐ Learn more: job-boards.greenhouse.io/ansabiotechn...
11.09.2025 15:02 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
๐งช Synthetic DNA fuels some of todayโs biggest breakthroughs, but the way it's made matters. Check out our latest blog to learn more about chemical vs. enzymatic DNA synthesis: what's changing & why it matters.
๐ ansabio.com/blog/chemica...
10.09.2025 11:40 โ ๐ 6 ๐ 0 ๐ฌ 0 ๐ 0
Powering the discovery and development of advanced therapeutics with our genome engineering platforms and induced pluripotent stem cell (iPSC) technology since 2008.
Associate Professor of Genetics at Washington University in St. Louis. I write about genomics at https://www.thisgenomiclife.org
Biotech, Brit ex-pat, tennis enthusiast, scientist, editor, women in leadership - not in order of priority
I write about medicine at STAT. This is biology's century. Every data point has a face.
Editor-in-Chief of Science and Professor of Chemistry and Medicine at George Washington University. Opinions not those of AAAS. https://holdenthorp.substack.com/about #ActuallyAutistic
Oncologist serving people w/ cancer in #MedEd, #SciComm, #bcsm, & #PublicHealth. Past ASCO Ed Chair. Co-founder HCWvsHunger.org. #LongCovid #MedSky #OncSky
Team hope/good trouble/go high๐
https://www.hopkinsmedicine.org/profiles/details/tanya-prowell
Staff writer at Science, specializing in infectious diseases and immunology. Vaccine history geek. Hate outbreaks, love covering them. Serious surf addiction, occasional contributor to the incomparable Surfer's Journal.
CNN medical correspondent
Signal: MegTirrell.60
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
internet typist at the verge, known cat lady, zevon stan. she/hers/hesher
tip me: liz@theverge.com
Journalist at Mother Jones and elsewhere, author, writer of social media posts on micro-blogging sites. Tips to Amerlan@motherjones.com or on Signal, username annamerlan.30
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
Scientist, cancer geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
Artist-in-Residence at the National Academies of Sciences, Engineering & Medicine. Documenting science and the edges of human curiosity.
https://linktr.ee/ChrisMichel
Original news, reviews, analysis of tech trends, and expert advice on the most fundamental aspects of tech.
Senior editor, Endpoints News
Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
Iโm an editorial writer for the Philadelphia Inquirer focused on urban policy-transit, housing, and planning
๐คฉScience & PhD Life Podcast
๐คฃPhD Memes
๐Science Merch
๐ฐPhD related Blogs
๐: thestrugglingscientists.com
Join 960+ academics who read our biweekly newsletter here-->
thestrugglingscientists.com/newsletter
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Boards: Pfizer, Illumina, TempusAI, United Health